Report cover image

European Association for the Study of Diabetes (EASD): Annual Meeting 2025 Highlights

Publisher GlobalData
Published Sep 30, 2025
Length 20 Pages
SKU # GBDT20610490

Description

European Association for the Study of Diabetes (EASD): Annual Meeting 2025 Highlights

Summary

The European Association for the Study of Diabetes (EASD) is a leading academic, non-profit organization dedicated to advancing research, education, and care in the field of diabetes mellitus. Founded in 1965 and headquartered in Düsseldorf, Germany, EASD brings together scientists, clinicians, nurses, allied health professionals, and students from around the world who are interested in diabetes research and its clinical application.

EASD 2025 took place in Vienna, Austria, between 15-19 September 2025.GlobalData's infectious diseases team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this IDWeek 2025 Highlights report.

Scope

Indications, companies, and therapies discussed -
    GLP-1RAs
      - Novo Nordisk – Semaglutide & Cagrilintide
    Cardiovascular Disease
      - Regeneron Pharmaceuticals & Sanofi – Alirocumab
    Resistant Hypertension
      - AstraZeneca – Baxdrostat
    Type 1 & Type 2 Diabetes
      - SAB Biotherapeutics – SAB-142- Vertex Pharmaceuticals – VX-880
    And more!

    Reasons to Buy

    This powerpoint-based deliverable provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Type 1 Diabetes, Type 2 Diabetes, Obesity, Heart Failure, Dyslipidemia, and more.

    Inside the report you’ll find -
    • Emerging trends in cardiovascular and metabolic indications
    • Insights into the disease areas that took precedence at the conference
    • Key takeaways from headline sessions and late-breaking data
    • Clinical and commercial implications of notable presentations

    Table of Contents

    20 Pages
    1. Conference Overview
    2. Industry Session Overview
    3. Conference Analysis by Key Therapy
    4. Key Presentations -
    GLP-1RAs
    Cardiovascular Disease
    Resistant Hypertension
    Type 1 & Type 2 Diabetes
    5. Appendix

    Search Inside Report

    How Do Licenses Work?
    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.